FORWARD FEATURES CALENDAR

Launches & Fundraising

Revere VC closes seed round at USD1.35m

Revere VC, a San Francisco and Hong Kong based asset management firm, has launched The Portal, a curated VC platform, and its inaugural fund strategy, the Prime Access Fund.   In addition, Revere VC also announced the close of its seed round at USD1.35 million, with participation from strategic equity

Park Square Capital raises EUR2.2bn for fourth subordinated debt fund

Park Square Capital (Park Square) has held the final closing of its fourth subordinated debt fund, resulting in total investable capital of EUR2.2 billion.  Park Square Capital Partners IV and related vehicles (PSCP IV) raised EUR1.8 billion of equity commitments, exceeding its target of EUR1.5 billion. Including committed leverage, the

Flexstone Partners’ Global Opportunities IV offering raises USD322m at second close

Flexstone Partners’ Global Opportunities IV, has attracted USD322 million of commitments after a first close in November 2020 and has already completed three investments. Like its predecessors, the fund is backed by long-standing Flexstone Partners investors, including Natixis, as well as new, top-tier Institutional investors in Europe, Australia and Asia.

New State Capital Partners Fund III closes at USD450m

New State Capital Partners (New State) has closed its third institutional investment fund, New State Capital Partners Fund III with USD450 million in committed capital.  The Fund was over-subscribed and closed on schedule at its hard cap in about four months after the official launch. Fund III’s investors are comprised

Wasabi Secures USD112m in Series C Financing

Wasabi, the hot cloud storage company, has secured USD112 million in Series C funding led by Fidelity Management & Research Company with participation from existing investors.  The round follows Wasabi’s USD27.5 million in debt financing announced in January. The C round brings Wasabi’s total equity financing to USD219 million.  The

CVS Health launches USD100m venture fund

CVS Health has launched CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler. “Consumers deserve a better health experience, one that puts them at the centre of cutting-edge, digitally enabled

CAPZA closes its unitranche fund CAPZA 5 Private Debt at EUR1.6bn

CAPZA has held the final closing of its CAPZA 5 Private Debt fund above its target with an investment capacity of EUR1.6 billion, exceeding the final closing of the previous fund (EUR950 million). This fifth vintage will finance SMEs with an EBITDA of more than EUR12 million through unitranche and

Polish VC investment fund Freya Capital joins PFR Starter programme

Freya Capital a venture capital fund that aims to provide investment support to early-stage companies has been added to the latest edition of the Polish Development Fund (PFR) Starter programme. The total capitalisation of Freya Capital is PLN64 million.  Freya Capital intends to invest in seed/early-stage companies operating in Europe,

NB Partners Fund III closes at USD500m hard cap

Boston-based NorthBridge Partners (NorthBridge) and New York-based Park Madison Partners have announced the final close of NB Partners Fund III, LP (Fund III), which was oversusbcribed at its USD500 million hard cap.  Investors in the fund included a mix of public and private pensions, foundations, asset managers, family offices, and

Main Sequence announces new AUD250m fund to ‘solve the world’s biggest challenges’

Main Sequence, Australia’s deep tech investment fund founded by Australia’s national science agency, CSIRO, has raised AUD250m for its second fund.  The oversubscribed raise was supported by returning investors including Horizons Ventures, Hostplus, Lockheed Martin and Temasek, as well as family offices and private investors from Morgan Stanley Wealth Management

Events

12 November, 2026 – 5:00 pm

Directory Listings